Lobbying for cannabis reform in the U.S. Congress has evolved from a fringe issue a decade ago to a political priority that, this year alone, has absorbed more than $3 million and scores of registered lobbyists in Washington DC.
And depending on how the Nov. 3 general election plays out, the marijuana lobbying landscape could become even pricier – and crowded – in 2021 and beyond, insiders said. Though that assumes major federal reform might be in the offing.
If Congress moves closer to passing a bill to legalize marijuana, it’s likely lobbying efforts and spending will intensify, given that a crucial question is how the federal government would regulate a national cannabis industry.
Such a question would interest corporate behemoths in the pharmaceutical and alcohol industries, for instance, as well as other sectors wanting to influence how any federal cannabis regulatory framework is crafted.